Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues

Date:




The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related